Back to Awarded Treatment Trials


Awarded Trial: 17T-003

Grant ID

17T-003

Illness

Schizophrenia

Primary Drug/Intervention

Methotrexate

Primary Dosage

15 mg/week

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Preparing to start

Investigator

Mark Weiser

Sample Size

100

Duration of Study Period for Each Subject

112 days

Outcome Measurements

Primary outcome measure: PANSS positive score at the end of the trial. Secondary outcome measures: PANSS total, negative and general psychopathology scales, Clinical Global Impression Scale-Severity (CGI-S) and Global Impression Scale-Improvement (CGI-I), Social Functioning Scale Assessment (PSP) and rates of drop outs before the end of the trial.

Results

N/A

Publication

N/A

Link

N/A

PI Name

Mark Weiser

Degree

MD

Center

N/A

Institution

Sheba Medical Center

Address

Tel Hashomer

City or Town

Ramat Gan

State or Province

N/A

Zip or Postal Code

N/A

Country

Israel

Email Address

mweiser@netvision.net.il